Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

ADVAIR DISKUS (Fluticasone Propionate and Salmeterol Xinafoate) Inhalation Powder
Company:  Glaxo Wellcome Inc.
Application No.:  21-077
Approval Date: 8/24/2000


Date created: February 03, 2003

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.